Abbott and AbbVie's Last Hurrah

By Brenton Flynn – Jan 22, 2013 at 4:30PM

NYSE: ABT

Abbott Laboratories

Market Cap

$182B

Today's Change

(-0.26%) -$0.27

Current Price

$104.67

Price as of May 9, 2024, 4:00 p.m. ET

For the last time, investors will see combined results from Abbott Labs and AbbVie

With another earnings season upon us, the Fool's health-care team is busy making sure investors know what to expect from their favorite companies this quarter, while also maintaining a focus on the long term.

In this video segment, health-care bureau chief Brenton Flynn discusses the upcoming earnings report from Abbott Labs (ABT -0.26%) and AbbVie (ABBV -0.03%). As Brenton notes, this is the last time that investors will see combined results from these now-separate companies.

Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.